Skip to main content
2024 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Certified Pharmacy Executive Leader
Digital Health & Informatics
Digital Health & Informatics
Diversity, Equity and Inclusion
Diversity, Equity and Inclusion
Health & Wellness
Health & Wellness
Opioids & Pain Management
Opioids & Pain Management
Sterile Compounding
Sterile Compounding

W. Mike Heath ASHP Federal Forum

(1-241) Discontinuation of Tyrosine Kinase Inhibitor (TKI) Therapy in Select Chronic Myeloid Leukemia (CML) Patients Within Veterans Integrated Services Network (VISN) 21

Sunday, December 8, 2024
3:30 PM – 5:00 PM  
Location: Hall G, Lower Level
Category: Research-in-Progress
Topic: Oncology/Hematology
Co-Author(s): Jenna Carmichael, Janice Taylor, Steve Flynn, David Huberman